3 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
Follow Epilepsy: new trials by email Literature Review of Epilepsy trials Research Report on Epilepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil Padsevonil type 1 Tablet 200 mg, Padsevonil type 2 Tablet, Padsevonil type 3 Tablet - Healthy Participants, Epilepsy | Phase 1 | Withdrawn | UCB Biopharma SRL | 2020-02-24 | 2020-06-22 | |
| Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation - Epilepsy | Phase 1 | Withdrawn | NYU Langone Health | 2012-11-01 | 2016-04-15 | |
| Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects Retigabine - Epilepsy, Partial | Phase 1 | Withdrawn | GlaxoSmithKline | 2012-10-10 | 2018-09-17 |
Depression (1) · Epilepsies, Partial (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Behavior (1) · Behavioral Symptoms (1)
Transcranial Direct Current Stimulation (1) · ezogabine (1)
GlaxoSmithKline (1) · NYU Langone Health (1) · UCB Biopharma SRL (1)
Japan (1) · United States (1)
Anli Liu, MD (1)